![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Retreatment of Patients Who Failed Prior Sofosbuvir-Based Regimens With All Oral Fixed-Dose Combination Ledipasvir/Sofosbuvir Plus Ribavirin for 12 Weeks
|
|
|
Reported by Jules Levin
AASLD 2014 Boston Nov 7-11
David Wyles1, Paul Pockros2, Yanni Zhu3, Jenny C. Yang3, Phillip S. Pang3, John G. McHutchison3, Steven Flamm4, Eric Lawitz5
1University of California, San Diego, CA; 2Scripps Clinic, La Jolla, CA; 3Gilead Sciences, Inc., Foster City, CA; 4Northwestern University Feinberg School of Medicine, Chicago, IL; 5Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX
![AASLD1.gif](../images/111414/111414-2/AASLD1.gif)
![AASLD2.gif](../images/111414/111414-2/AASLD2.gif)
![AASLD3.gif](../images/111414/111414-2/AASLD3.gif)
![AASLD4.gif](../images/111414/111414-2/AASLD4.gif)
![AASLD5.gif](../images/111414/111414-2/AASLD5.gif)
![AASLD6.gif](../images/111414/111414-2/AASLD6.gif)
![AASLD7.gif](../images/111414/111414-2/AASLD7.gif)
![AASLD8.gif](../images/111414/111414-2/AASLD8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|